Evidence map›Paper›PMID 40475956›Full record

ArticleFrontiers in medicine2025

Predicting the invasiveness of pulmonary adenocarcinoma using intratumoral and peritumoral radiomics features.

Jingjing Hong, Liyang Yang, Jiekun Huo, Guoci Huang, Bowen Shan, Tingting Cai, Lianlian Zhang, Weikang Huang, Ge Wen

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jingjing HongNanfang Hospital, Southern Medical University, Guangzhou, China.
Liyang YangNanfang Hospital, Southern Medical University, Guangzhou, China.
Jiekun HuoNanfang Hospital, Southern Medical University, Guangzhou, China.
Guoci HuangNanfang Hospital, Southern Medical University, Guangzhou, China.
Bowen ShanNanfang Hospital, Southern Medical University, Guangzhou, China.
Tingting CaiNanfang Hospital, Southern Medical University, Guangzhou, China.
Lianlian ZhangNanfang Hospital, Southern Medical University, Guangzhou, China.
Weikang HuangNanfang Hospital, Southern Medical University, Guangzhou, China.
Ge WenNanfang Hospital, Southern Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the predictive value of CT radiomics features within and surrounding tumors in determining the invasiveness of primary solitary nodular pulmonary adenocarcinoma. Methods: This retrospective study analyzed 107 patients with pathologically confirmed nodular pulmonary adenocarcinoma who underwent conventional non-enhanced CT Scans in our hospital from 2019 to 2023. Patients were categorized as non-invasive or invasive based on pathology findings. Clinical and imaging data from both groups were collected and compared, and logistic regression was used to independent factors associated with invasiveness. Radiologists manually outlined 3-dimensional regions of intratumoral and peritumoral areas to extract radiomics features, creating separate intratumor, peritumor, and combined intra-peritumor radiomics models. Radiomics models were trained using LASSO with 10-fold cross-validation in training dataset. Additionally, integrated models combining radiomics with clinical data were developed: intratumor-clinical, peritumor-clinical, and an intra-peri-clinical models. Results: Of the 107 patients, 73 were in the non-invasive group (mean age 49.73 ± 13.92, 22 males) and 34 were in the invasive group (mean age 57.53 ± 12, 14 males). The clinical model identified average nodule diameter and vascular type as independent risk factors for invasiveness (both Conclusion: The combined model incorporating intratumor and peritumor radiomics features with clinical data showed significant value in predicting the invasiveness of nodular pulmonary adenocarcinoma, aiding in the precise selection of surgical methods.

Indexed as

intratumoralinvasivenessperitumoralpulmonary adenocarcinomaradiomic features

Identifiers

PMID40475956
PMCPMC12138377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.